Kent Imaging Appoints Glyn Jones, MD as Chief Medical Officer of Reconstructive Surgery

Glyn Jones, MD, FACS

An experienced healthcare executive and renowned reconstructive surgeon provide proven expertise and advice on the use of near-infrared imaging technology.

CALGARY, AB, CANADA, Oct. 25, 2022 /EINPresswire.com/ — Kent Imaging is pleased to announce the appointment of Glyn Jones, MD, FACS as Chief Medical Officer of Reconstructive Surgery.

Dr. Jones is dedicated to excellence in reconstructive and cosmetic surgery as a member of the American Society of Plastic Surgeons and the American Association of Plastic Surgeons. Dr. Jones was a full-time faculty member and associate professor of plastic surgery at Emory University for fifteen years, serving as acting chair of the department of plastic surgery, and was awarded the “Teacher of the Year” award. “. He then served as a professor at the University of Illinois College of Medicine at Peoria (UICOMP) for 15 years while simultaneously running a private practice. As a surgeon, he focused primarily on breast reconstruction for cancer, cosmetic surgery and the management of complex wounds.

In addition to lecturing extensively on breast reconstruction and plastic surgery, Dr. Jones has authored and edited numerous book chapters on these topics. He is the author/editor of the 3rd edition of Bostwick’s Plastic & Reconstructive Breast Surgery, which is recognized as the definitive reference in breast surgery for surgeons worldwide. He is also co-author of “Reconstructive Surgery: Anatomy, Techniques and Clinical Application”, with Michael Zenn.

As a pioneer in the clinical application of tissue assessment with SPY fluorescence imaging technology, Dr. Jones now brings his extensive clinical and scientific experience to the Kent team to advance surgical imaging and patient care.

“I am honored to be Kent Imaging’s Chief Medical Officer. Snapshot’s wearable technology has exciting potential for widespread use in reconstructive procedures and to have a significant impact on patient care,” says Dr Jones. He adds, “The device adds a defined endpoint that we as surgeons can understand and act upon. Using StO2 readings as a proxy for tissue blood flow, Snapshot helps physicians more accurately assess mastectomy skin flap viability intraoperatively without the use of dyes or injectables. »

“Dr. Jones is an internationally renowned plastic surgeon with a unique combination of clinical, business, and research experience. He is an authority on the commercialization and clinical application of surgical imaging technology. His insight and passion for reducing complications in all patients are an incredible asset to our team,” said Pierre Lemire, CEO of Kent Imaging. “We are delighted to have him join Kent Imaging to help optimize the use of SnapshotNIR in the surgical field.”

An early adopter and supporter of SnapshotNIR, Dr. Jones has been using the near infrared spectroscopy imaging device for 5 years. In his new role, Dr. Jones provides medical and clinical leadership for Kent Imaging to help lead its reconstructive surgery portfolio.

About Kent Imaging
Kent Imaging, located in Calgary, Alberta, Canada, is a leading near-infrared tissue oxygenation imaging innovator that develops, manufactures and markets medical technology that supports real-time decision making in wound care, vascular and surgical subspecialties. Kent holds several patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to help healthcare systems nationally and internationally. SnapshotNIR is backed by clinical evidence showing how it can help improve decision-making in wound care and speed healing time. Since gaining FDA and Health Canada clearance in 2017, the technology has been featured in several published papers and peer-reviewed posters. Applying knowledge gained from clinical trials to patient care promotes consistency of treatment and optimal outcomes. For more information visit www.kenimaging.com

Lea Pavlick
Kent Imaging
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Other